Page last updated: 2024-11-04

sulfadiazine and Infections, Mycobacterium

sulfadiazine has been researched along with Infections, Mycobacterium in 1 studies

Sulfadiazine: One of the short-acting SULFONAMIDES used in combination with PYRIMETHAMINE to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections.
sulfadiazine : A sulfonamide consisting of pyrimidine with a 4-aminobenzenesulfonamido group at the 2-position.
diazine : The parent structure of the diazines.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Heironimus, JD1
Winn, RE1
Collins, CB1

Other Studies

1 other study available for sulfadiazine and Infections, Mycobacterium

ArticleYear
Cutaneous nonpulmonary Mycobacterium chelonei infection. Successful treatment with sulfonamides in an immunosuppressed patient.
    Archives of dermatology, 1984, Volume: 120, Issue:8

    Topics: Drug Combinations; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Kidney Failure, Chro

1984